Cargando…

Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has a high mortality rate due to limited treatment options. Hence, the response of HCC to different cancer immunotherapies is being intensively investigated in clinical trials. Immune checkpoint blockers (ICB) show promis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hage, Carina, Hoves, Sabine, Ashoff, Mailin, Schandl, Veronika, Hört, Stefan, Rieder, Natascha, Heichinger, Christian, Berrera, Marco, Ries, Carola H., Kiessling, Fabian, Pöschinger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619768/ https://www.ncbi.nlm.nih.gov/pubmed/31291357 http://dx.doi.org/10.1371/journal.pone.0219517

Ejemplares similares

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
por: Kashyap, Abhishek S., et al.
Publicado: (2020)

The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models
por: Maser, Ilona-Petra, et al.
Publicado: (2020)

Noninvasive Bioluminescence Imaging of AKT Kinase Activity in Subcutaneous and Orthotopic NSCLC Xenografts: Correlation of AKT Activity with Tumor Growth Kinetics()
por: Suchowski, Karina, et al.
Publicado: (2017)

Intrinsic Respiratory Gating for Simultaneous Multi-Mouse μCT Imaging to Assess Liver Tumors
por: Thamm, Mirko, et al.
Publicado: (2022)

SYST-31 PROBIOTIC DELIVERY TO ORTHOTOPIC GLIOBLASTOMA MULTIFORME MODELS AS AN IMMUNOTHERAPY
por: Windemuth, Sophia, et al.
Publicado: (2023)

A novel role for granzymes in anti-tumor immunity
por: Hoves, Sabine, et al.
Publicado: (2012)

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
por: Doleschel, Dennis, et al.
Publicado: (2021)

A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2023)

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
por: Domingos-Pereira, Sonia, et al.
Publicado: (2022)

Immunotherapy for Refractory Autoimmune Encephalitis
por: Yang, Jiawei, et al.
Publicado: (2021)

α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts
por: Nakagiri, Tomoyuki, et al.
Publicado: (2021)

Cellular immunotherapy for refractory hematological malignancies
por: Reagan, John L, et al.
Publicado: (2013)

Targeting hormone refractory prostate cancer by in vivo selected DNA libraries in an orthotopic xenograft mouse model
por: Civit, Laia, et al.
Publicado: (2019)

Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
por: Venuti, Aldo, et al.
Publicado: (2015)

Riboflavin-Targeted Drug Delivery
por: Darguzyte, Milita, et al.
Publicado: (2020)

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response
por: Zafarnia, Sara, et al.
Publicado: (2017)

Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model
por: Ashur-Fabian, Osnat, et al.
Publicado: (2019)

Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels
por: Zhuang, Bo, et al.
Publicado: (2022)

Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
por: Liu, Bao, et al.
Publicado: (2022)

Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy
por: Zhou, Ying, et al.
Publicado: (2022)

Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy
por: Wang, Jin, et al.
Publicado: (2022)

Evolving role of immunotherapy in the treatment of refractory warts
por: Thappa, Devinder M, et al.
Publicado: (2016)

Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
por: Merker, Michael, et al.
Publicado: (2019)

Orthotopic neobladder reconstruction
por: Chang, Dwayne T. S., et al.
Publicado: (2015)

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
por: Hoves, Sabine, et al.
Publicado: (2018)

The Corona mortis is similar in size to the regular obturator artery, but is highly variable at the level of origin: an anatomical study
por: Heichinger, René, et al.
Publicado: (2022)

Arquitectura de una pc en general /
por: Lopez Berrera, Eliud Gabriel
Publicado: (2001)

Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
por: Yan, Chi, et al.
Publicado: (2023)

Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021)

The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020)

TREATMENT OF TRIPLE-CLASS REFRACTORY DISEASE: BEYOND IMMUNOTHERAPY
por: Gavriatopoulou, M.
Publicado: (2023)

Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer
por: Wei, Jiaojie, et al.
Publicado: (2019)

Orthotopic Liver Transplantation in Rats
por: Oldani, Graziano, et al.
Publicado: (2012)

Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation
por: Hashemi, Mohammad, et al.
Publicado: (2011)

Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer()()
por: Fiegle, E, et al.
Publicado: (2019)

Syngeneic N1-S1 Orthotopic Hepatocellular Carcinoma in Sprague Dawley Rat for the Development of Interventional Oncology-Based Immunotherapy: Survival Assay and Tumor Immune Microenvironment
por: Choi, Bongseo, et al.
Publicado: (2023)

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
por: Fast, Loren, et al.
Publicado: (2013)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
por: Hallam, Simon
Publicado: (2018)

Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer
por: Rathi, Nityam, et al.
Publicado: (2020)

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
por: Marin-Acevedo, Julian A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1biqqso753n9st4sfkjq7nluk1